← Back to directory

Jens Mogensen

Researcher Next ID · RN-027382

Researcher · Medicine

Trinity College

Toronto, Ireland

Not currently recruitingFunding unknown
Works count
1,461
Citation count
22,510
H-index
47
i10-index
106

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Cardiomyopathy and Myosin Studies
Metabolism and Genetic Disorders
Cardiovascular Effects of Exercise
Liver Disease Diagnosis and Treatment
Cardiac Arrhythmias and Treatments

Publications

  • 2023 ESC Guidelines for the management of cardiomyopathies

    European Heart Journal · 2023 · https://doi.org/10.1093/eurheartj/ehad194

  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31792-x

  • Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene

    Circulation Heart Failure · 2020 · 10.1161/circheartfailure.119.006832

  • Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)

    JAMA Cardiology · 2019 · https://doi.org/10.1001/jamacardio.2019.2861

  • Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations

    Journal of the American College of Cardiology · 2018 · 10.1016/j.jacc.2018.08.2181

  • Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations

    Journal of the American College of Cardiology · 2018 · 10.1016/j.jacc.2018.08.2181

  • International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)

    Circulation · 2017 · https://doi.org/10.1161/circulationaha.117.030437

  • Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

    European Heart Journal · 2016 · https://doi.org/10.1093/eurheartj/ehv727

  • Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

    European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu217

  • 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

    European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu284

  • Atlas of the clinical genetics of human dilated cardiomyopathy

    European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu301

  • Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

    European Heart Journal · 2013 · https://doi.org/10.1093/eurheartj/eht210

  • Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers

    Journal of the American College of Cardiology · 2012 · https://doi.org/10.1016/j.jacc.2011.08.078

  • Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases

    European Heart Journal · 2012 · https://doi.org/10.1093/eurheartj/ehs397

  • Prevalence, Clinical Significance, and Genetic Basis of Hypertrophic Cardiomyopathy With Restrictive Phenotype

    Journal of the American College of Cardiology · 2007 · https://doi.org/10.1016/j.jacc.2007.02.061

  • Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy

    European Heart Journal · 2006 · https://doi.org/10.1093/eurheartj/ehl041

  • Novel Mutation in Desmoplakin Causes Arrhythmogenic Left Ventricular Cardiomyopathy

    Circulation · 2005 · https://doi.org/10.1161/circulationaha.104.532234

  • Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome

    Journal of the American College of Cardiology · 2005 · 10.1016/j.jacc.2004.11.053

  • Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy

    Heart · 2005 · 10.1136/hrt.2003.031161

  • Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy

    Journal of the American College of Cardiology · 2004 · https://doi.org/10.1016/j.jacc.2004.08.027

  • Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy

    The Lancet · 2004 · 10.1016/s0140-6736(04)15468-8

  • Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations

    Journal of Clinical Investigation · 2003 · https://doi.org/10.1172/jci16336

  • Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations

    Journal of Clinical Investigation · 2003 · https://doi.org/10.1172/jci200316336

  • α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy

    Journal of Clinical Investigation · 1999 · https://doi.org/10.1172/jci6460

Current projects

    No projects listed.